NeuroOne® Awarded U.S. Patent Covering Novel and Proprietary Thin Film Electrode Platform

New patent adds value to NeuroOne’s growing patent portfolio in the U.S. and abroad EDEN PRAIRIE, Minn., March 7, 2023 /PRNewswire/ — NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) (“NeuroOne” or the “Company”), a medical technology company focused on improving surgical care…